134 related articles for article (PubMed ID: 35105935)
1. Systemic adjuvant chemotherapy for advanced malignant ocular medulloepithelioma.
Sheriff IHN; Karaa EK; Chowdhury T; Scheimberg I; Duncan C; Reddy MA; Sagoo MS
Eye (Lond); 2023 Apr; 37(5):947-952. PubMed ID: 35105935
[TBL] [Abstract][Full Text] [Related]
2. Ocular medulloepithelioma chemosensitivity.
Meel R; Chawla B; Mohanti BK; Kashyap S; Bakhshi S
Ophthalmology; 2010 Dec; 117(12):2440.e1-2. PubMed ID: 20947172
[No Abstract] [Full Text] [Related]
3. Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma.
Kaliki S; Shields CL; Shah SU; Eagle RC; Shields JA; Leahey A
Arch Ophthalmol; 2011 Nov; 129(11):1422-7. PubMed ID: 22084213
[TBL] [Abstract][Full Text] [Related]
4. Malignant transformation of a medulloepithelioma of the optic nerve.
Lindegaard J; Heegaard S; Toft PB; Nysom K; Prause JU
Orbit; 2010 Jun; 29(3):161-4. PubMed ID: 20497085
[TBL] [Abstract][Full Text] [Related]
5. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Singh A; Friedman DL; Naduvilath TJ
Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863
[TBL] [Abstract][Full Text] [Related]
6. Management and outcome of retinoblastoma with vitreous seeds.
Manjandavida FP; Honavar SG; Reddy VA; Khanna R
Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
[TBL] [Abstract][Full Text] [Related]
7. Ciliary body medulloepithelioma: analysis of 41 cases.
Kaliki S; Shields CL; Eagle RC; Vemuganti GK; Almeida A; Manjandavida FP; Mulay K; Honavar SG; Shields JA
Ophthalmology; 2013 Dec; 120(12):2552-2559. PubMed ID: 23796765
[TBL] [Abstract][Full Text] [Related]
8. Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction.
Demirci H; Eagle RC; Shields CL; Shields JA
Arch Ophthalmol; 2003 Aug; 121(8):1125-31. PubMed ID: 12912690
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant/adjuvant treatment of high-risk retinoblastoma: a report from the German Retinoblastoma Referral Centre.
Künkele A; Wilm J; Holdt M; Lohmann D; Bornfeld N; Eggert A; Temming P; Schulte JH
Br J Ophthalmol; 2015 Jul; 99(7):949-53. PubMed ID: 25583279
[TBL] [Abstract][Full Text] [Related]
10. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
[TBL] [Abstract][Full Text] [Related]
11. Management of advanced retinoblastoma with intravenous chemotherapy then intra-arterial chemotherapy as alternative to enucleation.
Shields CL; Kaliki S; Al-Dahmash S; Rojanaporn D; Leahey A; Griffin G; Jabbour P; Shields JA
Retina; 2013; 33(10):2103-9. PubMed ID: 23873161
[TBL] [Abstract][Full Text] [Related]
12. Intra-arterial chemotherapy as primary or secondary treatment for infants diagnosed with advanced retinoblastoma before 3 months of age.
Chen Q; Zhang B; Dong Y; Mo X; Zhang L; Xia J; Zhang J; Zhang S
BMC Cancer; 2019 Jul; 19(1):693. PubMed ID: 31307410
[TBL] [Abstract][Full Text] [Related]
13. Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors.
Shields CL; Mashayekhi A; Cater J; Shelil A; Ness S; Meadows AT; Shields JA
Arch Ophthalmol; 2005 Jun; 123(6):765-73. PubMed ID: 15955977
[TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy for primitive neuroectodermal and other malignant brain tumours.
Gaze MN; Smith DB; Rampling RP; Simpson E; Barrett A
Clin Oncol (R Coll Radiol); 1994; 6(2):110-5. PubMed ID: 8018568
[TBL] [Abstract][Full Text] [Related]
15. Medulloepithelioma of the ciliary body.
al-Torbak A; Abboud EB; al-Sharif A; el-Okda MO
Indian J Ophthalmol; 2002 Jun; 50(2):138-40. PubMed ID: 12194573
[TBL] [Abstract][Full Text] [Related]
16. Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.
Miser JS; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Grier HE
J Clin Oncol; 2004 Jul; 22(14):2873-6. PubMed ID: 15254055
[TBL] [Abstract][Full Text] [Related]
17. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
[TBL] [Abstract][Full Text] [Related]
18. Malignant non-teratoid medulloepithelioma of the optic nerve with intraocular extension.
Pushker N; Shrey D; Bajaj MS; Kashyap S; Yadav P; Mehta M; Bakhshi S
Clin Exp Ophthalmol; 2010 Oct; 38(7):731-3. PubMed ID: 20497433
[TBL] [Abstract][Full Text] [Related]
19. Delayed Enucleation With Neoadjuvant Chemotherapy in Advanced Intraocular Unilateral Retinoblastoma: AHOPCA II, a Prospective, Multi-Institutional Protocol in Central America.
Luna-Fineman S; Chantada G; Alejos A; Amador G; Barnoya M; Castellanos ME; Fu L; Fuentes-Alabi S; Girón V; Goenz MA; Maldonado C; Méndez G; Morales RA; Ortiz R; Sanchez G; Wilson M; Rodríguez-Galindo C
J Clin Oncol; 2019 Nov; 37(31):2875-2882. PubMed ID: 31536438
[TBL] [Abstract][Full Text] [Related]
20. A 10-year experience of outcome in chemotherapy-treated hereditary retinoblastoma.
Bartuma K; Pal N; Kosek S; Holm S; All-Ericsson C
Acta Ophthalmol; 2014 Aug; 92(5):404-11. PubMed ID: 24119165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
